Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants

Background: Azvudine (FNC) is a promising treatment candidate for managing coronavirus disease 2019 (COVID-19). However, drug interactions with azvudine have been poorly studied, especially with no reported cases of azvudine with anticoagulants such as warfarin and rivaroxaban. Case summary: The pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Jiao, Fengwei, Li, Guangrun, Yu, Xiaojia, Pei, Yuqing, Zhang, Ying, Wang, Zihui, Li, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235595/
https://www.ncbi.nlm.nih.gov/pubmed/37274098
http://dx.doi.org/10.3389/fphar.2023.1191608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235595/
https://www.ncbi.nlm.nih.gov/pubmed/37274098
http://dx.doi.org/10.3389/fphar.2023.1191608

Ejemplares similares